Letters to the editor
Withdrawal reactions of a premature neonate after maternal use of paroxetine
| The first 150 words of the full text of this article appear below. |
EDITOR
Paroxetine is an antidepressant of the
selective serotonin reuptake inhibitor (SSRI) group. Its use during
pregnancy can lead to premature birth and neonatal withdrawal symptoms.
A girl was born after 35+2 weeks gestation (birth weight 2690 g) and admitted because of prematurity. The pregnancy and delivery had been uneventful (Apgar score 9/10/10), with no apparent reason for prematurity. There were no problems in the first few days and she drank quickly (bottle feeding).
Thereafter she became irritable, lethargic, and needed tube feeding.
She was hypertonic, apathetic, and jittery. The Finnegan score, a
behaviour score for neonatal withdrawal reactions, was from day 1 to
10: 0, 0, 2, 2, 9, 9, 6, 6, 7, 7. There were no signs of infection;
opiate and metabolic screening were negative. Cerebral ultrasound and
an electroencephalogram were normal. The maternal use of paroxetine
seemed to be the explanation. The baby improved spontaneously and was
discharged at 37+6 weeks gestation. The Finnegan score had returned to
eLetters:
Read all eLetters
- Feeding difficulty in a term neonate due to Paroxetine withdrawl
- Jayesh Bhatt
- Fetal Neonatal Ed. Online, 31 Jan 2001 [Full text]
- prem birth/taking seroxat
- sarah elvin
- Fetal Neonatal Ed. Online, 26 Oct 2005 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



